151 related articles for article (PubMed ID: 11981114)
1. Molecular and biologic markers of premalignant lesions of human breast.
Krishnamurthy S; Sneige N
Adv Anat Pathol; 2002 May; 9(3):185-97. PubMed ID: 11981114
[TBL] [Abstract][Full Text] [Related]
2. Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology.
Lishman SC; Lakhani SR
Histopathology; 1999 Sep; 35(3):195-200. PubMed ID: 10469210
[TBL] [Abstract][Full Text] [Related]
3. Molecular and genetic abnormalities in radial scar.
Iqbal M; Shoker BS; Foster CS; Jarvis C; Sibson DR; Davies MP
Hum Pathol; 2002 Jul; 33(7):715-22. PubMed ID: 12196923
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer precursors revisited: molecular features and progression pathways.
Lopez-Garcia MA; Geyer FC; Lacroix-Triki M; Marchió C; Reis-Filho JS
Histopathology; 2010 Aug; 57(2):171-92. PubMed ID: 20500230
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
6. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast.
Tibiletti MG; Sessa F; Bernasconi B; Cerutti R; Broggi B; Furlan D; Acquati F; Bianchi M; Russo A; Capella C; Taramelli R
Clin Cancer Res; 2000 Apr; 6(4):1422-31. PubMed ID: 10778973
[TBL] [Abstract][Full Text] [Related]
7. Quantitative immunoprofiles of breast cancer performed by image analysis.
Querzoli P; Albonico G; Ferretti S; Rinaldi R; Magri E; Nenci I
Anal Quant Cytol Histol; 1999 Apr; 21(2):151-60. PubMed ID: 10560485
[TBL] [Abstract][Full Text] [Related]
8. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of COX-2, P53, and EZH-2 evaluated by quantitative image analysis in premalignant and malignant breast lesions.
Nicolopoulou-Stamati P; Tsipis A; Chelidonis G; Patsouris E; Athanassiadou P; Gonidi M; Athanassiadou AM
Diagn Cytopathol; 2015 Apr; 43(4):294-300. PubMed ID: 25355039
[TBL] [Abstract][Full Text] [Related]
10. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
[TBL] [Abstract][Full Text] [Related]
11. Premalignant and in situ breast disease: biology and clinical implications.
Arpino G; Laucirica R; Elledge RM
Ann Intern Med; 2005 Sep; 143(6):446-57. PubMed ID: 16172443
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
Hoogerbrugge N; Bult P; de Widt-Levert LM; Beex LV; Kiemeney LA; Ligtenberg MJ; Massuger LF; Boetes C; Manders P; Brunner HG
J Clin Oncol; 2003 Jan; 21(1):41-5. PubMed ID: 12506168
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study.
McLaren BK; Gobbi H; Schuyler PA; Olson SJ; Parl FF; Dupont WD; Page DL
Am J Surg Pathol; 2005 Jan; 29(1):105-8. PubMed ID: 15613861
[TBL] [Abstract][Full Text] [Related]
14. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
15. TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
Chitemerere M; Andersen TI; Holm R; Karlsen F; Børresen AL; Nesland JM
Breast Cancer Res Treat; 1996; 41(2):103-9. PubMed ID: 8944328
[TBL] [Abstract][Full Text] [Related]
16. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
Dauplat MM; Penault-Llorca F
Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer.
Lakhani SR
Mol Pathol; 2001 Oct; 54(5):281-4. PubMed ID: 11577167
[TBL] [Abstract][Full Text] [Related]
18. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
[TBL] [Abstract][Full Text] [Related]
19. Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer.
Mastracci TL; Boulos FI; Andrulis IL; Lam WL
Breast Cancer Res; 2007; 9(6):215. PubMed ID: 18036272
[TBL] [Abstract][Full Text] [Related]
20. [Establishing a cytogenetic and morphological progression models of invasive breast cancer. Comparative genomic hybridization (CGH) in malignant and premalignant tumors of the female breast].
Bürger H; Poremba C; Diallo R; Dockhorn-Dworniczak B; Böcker W
Pathologe; 2000 Sep; 21(5):375-82. PubMed ID: 11092010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
